Adrenergic control of protein and fat metabolism in healthy adults

Impact of beta2-adrenergic stimulation on protein and fat metabolism in healthy adults

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000161022

Enrollment

Registered

2010-02-18

Start date

2009-08-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study objective is to investigate the metabolic effects of beta2-agonist in humans, including whole body energy expenditure, fat oxidation, protein synthesis and turnover

Interventions

Oral administration of a beta2-agonist (oral formoterol tablet 160 mg daily for 1 week)

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

Healthy adults

Exclusion criteria

Any active medical conditions necessitating medication

Outcome results